SE449753B - Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav - Google Patents
Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning deravInfo
- Publication number
- SE449753B SE449753B SE7909087A SE7909087A SE449753B SE 449753 B SE449753 B SE 449753B SE 7909087 A SE7909087 A SE 7909087A SE 7909087 A SE7909087 A SE 7909087A SE 449753 B SE449753 B SE 449753B
- Authority
- SE
- Sweden
- Prior art keywords
- concentration
- yin
- fractions
- units
- mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8128—Antithrombin III
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Materials Engineering (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7831357A FR2440376A1 (fr) | 1978-11-06 | 1978-11-06 | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
FR7918873A FR2461719A2 (fr) | 1979-07-20 | 1979-07-20 | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7909087L SE7909087L (sv) | 1980-05-07 |
SE449753B true SE449753B (sv) | 1987-05-18 |
Family
ID=26220837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7909087A SE449753B (sv) | 1978-11-06 | 1979-11-01 | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav |
Country Status (6)
Country | Link |
---|---|
US (1) | US4486420A (it) |
JP (1) | JPH03243601A (it) |
DE (1) | DE2944792C3 (it) |
GB (1) | GB2035349B (it) |
IT (1) | IT1126319B (it) |
SE (1) | SE449753B (it) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692435A (en) * | 1978-11-06 | 1987-09-08 | Choay, S.A. | Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation |
FR2478646A2 (fr) * | 1980-03-20 | 1981-09-25 | Choay Sa | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
FR2503714B1 (fr) * | 1981-04-10 | 1986-11-21 | Choay Sa | Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine |
IT1163772B (it) * | 1983-07-13 | 1987-04-08 | Baldacci Lab Spa | Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche |
FR2568774B2 (fr) * | 1984-05-30 | 1989-05-19 | Choay Sa | Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique |
CA1260461A (fr) * | 1984-10-18 | 1989-09-26 | Jean-Claude Lormeau | Procede de preparation de compositions de mucopolysaccharides dotes d'une activite antithrombotique elevee |
US4788307A (en) * | 1986-04-30 | 1988-11-29 | Choay S.A. | Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity |
US4942156A (en) * | 1986-08-20 | 1990-07-17 | Hepar Industries, Inc. | Low molecular weight heparin derivatives having improved anti-Xa specificity |
US4745106A (en) * | 1986-08-20 | 1988-05-17 | Griffin Charles C | Heparin derivatives having improved anti-Xa specificity |
USRE38743E1 (en) | 1990-06-26 | 2005-06-14 | Aventis Pharma S.A. | Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events |
GB9206291D0 (en) * | 1992-03-23 | 1992-05-06 | Cancer Res Campaign Tech | Oligosaccharides having growth factor binding affinity |
DK0946185T4 (da) * | 1996-11-27 | 2010-08-30 | Aventis Pharma Inc | Farmaceutisk præparat, som omfatter en forbindelse med anti-Xa-aktivitet og en blodpladeaggregations antagonistforbindelse |
EP0986581A1 (en) * | 1997-06-06 | 2000-03-22 | Hamilton Civic Hospitals Research Development, Inc. | Modified low molecular weight heparin that inhibits clot associated coagulation factors |
EP1190364A2 (en) | 1999-04-23 | 2002-03-27 | Massachusetts Institute Of Technology | System and method for polymer notation |
MXPA02000142A (es) * | 1999-06-30 | 2003-07-21 | Hamilton Civic Hospitals Res | Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo. |
CN1473061A (zh) * | 2000-09-08 | 2004-02-04 | ���ܶ�����ҽԺ�о���չ����˾ | 抗血栓形成的组合物 |
AU2009250803A1 (en) * | 2008-05-20 | 2009-11-26 | Crystal Clear Partnership | Separation of polysaccharides by charge density gradient |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1042001A (en) * | 1973-04-13 | 1978-11-07 | Choay S.A. | Mixed heparin salts |
SE431218B (sv) * | 1976-03-05 | 1984-01-23 | Kabi Ab | Forfarande for rening av heparin |
IT1083903B (it) * | 1977-08-09 | 1985-05-25 | Lobo Srl | Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche |
US4122250A (en) * | 1977-08-22 | 1978-10-24 | Gottfried Schmer | Separation of high-activity heparin by affinity chromatography |
US4175182A (en) * | 1978-07-03 | 1979-11-20 | Research Corporation | Separation of high-activity heparin by affinity chromatography on supported protamine |
CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
HU177887B (en) * | 1979-03-21 | 1982-01-28 | Richter Gedeon Vegyeszet | Process for preparing a raw material containing heparin |
US4281108A (en) * | 1980-01-28 | 1981-07-28 | Hepar Industries, Inc. | Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained |
-
1979
- 1979-11-01 SE SE7909087A patent/SE449753B/sv not_active IP Right Cessation
- 1979-11-06 DE DE2944792A patent/DE2944792C3/de not_active Expired - Lifetime
- 1979-11-06 IT IT27064/79A patent/IT1126319B/it active Protection Beyond IP Right Term
- 1979-11-06 GB GB7938474A patent/GB2035349B/en not_active Expired
-
1981
- 1981-09-14 US US06/301,611 patent/US4486420A/en not_active Expired - Lifetime
-
1990
- 1990-11-27 JP JP2321340A patent/JPH03243601A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SE7909087L (sv) | 1980-05-07 |
DE2944792C2 (it) | 1994-04-14 |
IT1126319B (it) | 1986-05-21 |
DE2944792C3 (de) | 1994-04-14 |
IT7927064A0 (it) | 1979-11-06 |
GB2035349A (en) | 1980-06-18 |
DE2944792A1 (de) | 1980-05-14 |
JPH03243601A (ja) | 1991-10-30 |
GB2035349B (en) | 1983-05-11 |
US4486420A (en) | 1984-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4692435A (en) | Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation | |
SE449753B (sv) | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav | |
DK173385B1 (da) | Analogifremgangsmåde til fremstilling af oligosaccharidfraktioner eller oligosaccharider med specifik anti-Xa-aktivitet | |
JPH0323528B2 (it) | ||
DE3880577T2 (de) | Heparinderivate, verfahren zu deren herstellung und verwendung fuer pharmazeutische zwecke. | |
Young et al. | Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins | |
US4500519A (en) | Mucopolysaccharides having biological properties, preparation and method of use | |
Linhardt et al. | Homogeneous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitro. | |
JPH04503950A (ja) | 平滑筋細胞増殖のインヒビターとしてのヘパリン断片 | |
CN103209997B (zh) | 高纯度肝素及其制备方法 | |
Mulloy et al. | Assays and reference materials for current and future applications of heparins | |
USRE35770E (en) | Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them | |
Zhu et al. | Heparin contamination and issues related to raw materials and controls | |
Suda et al. | Structural characterization of heparin's binding domain for human platelets | |
Andermann et al. | The influence of the route of administration on the bioavailability of an endogenous macromolecule: chondroitin sulphate (CSA) | |
Wan et al. | Renal contribution to overall metabolism of drugs III: Metabolism of p‐aminobenzoic acid | |
US4067964A (en) | Antihemophilic agent and process for its manufacture | |
EP2283045A1 (en) | Separation of polysaccharides by charge density gradient | |
US20220096530A1 (en) | Safe bovine heparin, preparation method, and application | |
Hanin et al. | Acetylcholine and choline in human plasma and red blood cells: a gas chromatograph mass spectrometric evaluation | |
Ayotte et al. | Influence of variations in the chemical structure of heparin on its anticoagulant and anti-factor Xa activities | |
Hurst et al. | Partition techniques for isolation and fractionation of urinary glycosaminoglycans | |
Rădulescu et al. | The in vitro release profiles of nimesulide from oral solid dosage forms, in compendial and modified physiological media | |
Kretchmer et al. | Cellular mechanisms of protein metabolism in the nephron: V. The intracellular partition and the incorporation into protein of intravenously injected L-lysine | |
CN113230164A (zh) | 一种肉苁蓉鳞茎提取物的制备方法及改善透皮吸收效率中的应用、及经皮吸收效率检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7909087-4 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7909087-4 Format of ref document f/p: F |